疏风解毒胶囊治疗老年社区获得性肺炎患者的疗效评价  被引量:37

Effect Evaluation for Shufeng Jiedu Capsule in the Treatment of the Elderly Patients with Community-acquired Pneumonia

在线阅读下载全文

作  者:张连国[1] 滕国杰[1] 周玉涛[1] 

机构地区:[1]首都医科大学宣武医院呼吸科,北京100053

出  处:《中国医药导刊》2014年第12期1471-1472,1474,共3页Chinese Journal of Medicinal Guide

摘  要:目的:评价疏风解毒胶囊治疗老年社区获得性肺炎(community acquired pneumonia,CAP)的临床疗效及安全性。方法:将100例老年CAP病人入院随机分成治疗组与对照组。治疗组病人予莫西沙星静滴,0.4g/d,连续7日,同时予疏风解毒胶囊口服,每次4粒,每日3次,连续7日;对照组予莫西沙星静脉滴注,0.4g/d,连续7日。观察两组病人治疗前后主要临床症状、体征、感染性相关指标、胸片DR变化情况,并评定病人临床治疗效果、不良反应发生情况。结果:与对照组比较,治疗组主要临床症状、体征恢复时间明显缩短(P<0.05),退热疗效尤其显著(P<0.01),而且血白细胞、中性粒细胞比例、C反应蛋白及降钙素原等感染性指标在治疗后第3日显著降低(P<0.05,P<0.01),第7日基本恢复正常;胸部DR提示治疗组炎症病灶完全吸收率明显高于对照组(P<0.05);治疗组总有效率明显高于对照组(P<O.05)。两组均未见严重不良反应发生。结论:疏风解毒胶囊联合莫西沙星治疗能促进老年CAP病人临床症状的改善,加速病人恢复。Objective: To evaluate shufeng jiedu capsule(SFJDC) in the treatment of the elderly patients with community-acquired pneumonia(CAP) of clinical curative effect and security.Methods: 100 elderly inpatients with CAP were randomly divided into treatment group and control group.Treatment group with moxifloxacin, 0.4 g/d, meanwhile, taking SFJDC 4 pills, 3 times a day, for 7 days; control group with moxifloxacin, 0.4 g/d, for 7 days.Then, Observed the change of all of the patients' clinical performance, infectious related indicators and DR after treatment, and assessed the clinical curative effect and adverse reactions. Results: Major clinical symptoms and signs of recovery time of treatment group less than control group(P〈0.05), especially in defervescence(P〈0.01); the proportion of blood leukocytes and neutrophils, c-reactive protein and procalcitonin after 3 days for treatment group decreased significantly(P〈0.05, P〈0.01), the 7th to generally normal; inflammatory lesions absorption to treatment group was obviously faster than that of control group compared by DR(P〈0.05); the total curative effect for treatment group was higher than that of control group(P〈0.05).There were no serious adverse reactions in the two groups.Conclusion: SFJDC with moxifloxacin can promote the improvement of the clinical symptoms of old patients with CAP, and accelerate the patient's recovery.

关 键 词:疏风解毒胶囊 老年患者 社区获得性肺炎 疗效评价 

分 类 号:R563.19[医药卫生—呼吸系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象